期刊文献+

骨肉瘤多基因表达的同步检测 被引量:1

Multiple Genetic Expression Abnormalities in Osteosarcoma
下载PDF
导出
摘要 目的探讨骨肉瘤多基因表达的方法。方法通过免疫组化S-P法检测30例人骨肉瘤和15例正常骨组织中p16、MDM2、Rb和p53表达的情况,并进行统计学分析。结果30例骨肉瘤p16、MDM2、Rb、和p53表达阳性率分别为36.7%、76.7%、40%、63.3%;与正常骨组织相比,骨肉瘤组织中p16、Rb蛋白表达水平降低。MDM2和p53蛋白表达水平增高,其差异均有统计学意义(P<0.05);骨肉瘤中p16和Rb蛋白表达无相关关系;p53和MDM蛋白表达结果呈负相关关系。结论骨肉瘤的发生和多基因的改变及其联合作用有关。 Objective To evaluate the relationship of multiple - genetic expression abnormalities in human osteosarcoma. Methods By means of immunohistochemical S - P method,the expression of p16, MDM2, Rb, p53 were examined on 30 specimens of human osteosarcomas and 15 normal human bone tissues. Results The positive rate of p16, MDM2, Rb and p53 expressions was 36.7% ,76.7% ,40% ,63.3%. It was found that there were lower levels of expression of p16, Rb protein and higher levels of expression of MDM2, p53 protein in osteosarcomas,with a dramaticaly statistical difference in contrast to those in the normal bones ( P 〈0.05). The expression of p16 had no correlation with Rb expression. The expression of MDM2 correlated negatively with p53. Conclusion Mutiple gene abnormalities and their mutual interaction may play some role in the genesis of human osteosarcoma.
出处 《医药论坛杂志》 2005年第17期8-10,13,共4页 Journal of Medical Forum
关键词 骨肉瘤 癌基因 免疫组织化学 Osteosarcoma, Oncogene, Immunohistochemistry
  • 相关文献

参考文献5

  • 1Fromiwitz FB, Viola MV, Chao S, et al. Ras expression in the progression of breast cancer. Human Pathol, 1987,18:1268.
  • 2A1 Mohanna MA, Manogaran PS, A1 Mukhalafi Z, et al.The tumor suppressor p16(INK4a) gene is a reguahor of apoptosis induced by ultraviolet light and cisplatin. Oncogene ,2004,23 ( 1 ) :201-12.
  • 3Otte C, Scholz R, Werner M, et al. Methylation status of the retinoblastoma gene ( RB1 ) in osteosarcoma: no evidence for hypermethylation. Pediatr Hematol Oncol,2004,21 ( 1 ) :57-65.
  • 4Park HR,Jung WW, Bertoni F,et al. Molecular analysis of p53, MDM2 and H -ras genes in low- grade central osteosarcoma. Pathol Res Pract,2004,200(6) :439-45.
  • 5Greenblatt MS, Beaudet JG, Gump JR, et al. Detailed computational study of p53 and pl6:using evolutionary sequence analysis and disease- associated mutations to predict the functional consequences of allelic variants. Oncogene, 2003,22 ( 8 ) : 1150-63.

同被引文献16

  • 1杨迪生.骨肉瘤治疗的研究进展[J].浙江大学学报(医学版),2005,34(5):381-383. 被引量:4
  • 2周钢,杨述华.骨肉瘤化疗最新进展[J].中国骨肿瘤骨病,2006,5(6):372-375. 被引量:4
  • 3JUDITH ZHIYIE TAN,STEPHEN M SCHLICHT,GERARD J POWELL,et al.Muhidisciplinary approach to diagnosis and management of osteosarcoma-a review of the St Vincent's Hospital experience[J].International Seminars in Surgical Oncology 2006,3(38) : 1186-1190.
  • 4SETH D.BERMAN,ELIEZER CALO,ALLISON SLANDMAN et al.Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage [J].PNAS,2008,105 (33) : 11851 - 11856.
  • 5PIERO PICCI.Osleosarcoma (Osteogenic sarcoma) [J].Orphanet Journal of Rare Diseases, 2007,2 (6) : 375-379.
  • 6JENNIFER W.LISLE MD,JOSEPH Y,et al.Metastatic Osteosarcoma Gene Expression Differs In Vitro and In Vivo [J].Clin Orthop Relat Res, 2008,466 : 2071-2080.
  • 7FRANCOIS LAMOUREUX,PEGGY RICHARD,YOHANN WIT- TRANT,et al. Therapeutic Relevance of Osteoprotegerin Gene Therapy in Osteosarcoma:Blockade of the Vicious Cycle between Tumor Cell Proliferation and Bone Resorption [J].Cancer Res, 2007,67 (15) :7308-7318.
  • 8CARL R.WALKLEY,RAMEEZ QUDSI,VIJAY G,et al.Conditional mouse osteosarcoma,dependent on p53 loss and potentiated by loss of Rb, mimics the human disease [J].Genes Dev 2008,22(12) : 1662-1676.
  • 9RICHARD S.HOTCHKISS.M D,ANDREAS STRASSER,et al. Cell Death[J].N Engl J Med,2009,361:1570-83.
  • 10ADAMS JM, CORY S.Bc1-2 -regulated apoptosis :mechanism and therapeutic potential [J].Curr Opin Immunol,2007,19: 488-96.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部